欢迎来到QPS
定制化研究™
临床前和临床研究的全球领导者
为何选择QPS?
Partnering with the QPS Preclinical and Clinical teams is easy!
您决定与QPS合作后,我们将根据研究需要建立客户专属团队,以满足您的一切需求。 我们将指派一名经验丰富的项目经理,全面负责您的临床研究的开展,并将担任您的唯一联系人,以尽量提高灵活性和效率。
Agility
Agility
Flexibility
Flexibility
Speed
Speed
Quality
Quality
我们如何帮助您加快实现制药突破?
Toxicology, DMPK, Bioanalysis, Gene Therapy, Early and Late Phase Clinical Trials, Recruitment Services and Contract Research Support Services form the backbone of the broad range of QPS service offerings.
定制化研究服务组合
超过25年的经验!
凭借超过 25 年的经验、专注于药物开发各个方面的部门以及拥有数百年综合行业经验的高级领导团队,QPS 拥有独特的优势,能够成为您的合作伙伴。
DMPK服务
DMPK服务
毒理学
毒理学
生物分析
生物分析
检测方法检索器
检测方法检索器
临床开发
临床开发
提供全面服务的合同研究机构
QPS提供全面的临床研究服务。 我们可以为药企、生物技术公司和CRO合作伙伴提供全方位的支持。 作为临床前CRO,我们拥有必备的经验和知识,能够及时完成药品从测试阶段到临床试验的研究。 我们药物开发服务的广度和深度领先业界,期待向您介绍我们如何支持您的需求。
聚光灯
QPS Custom-Built Research
Agility. Flexibility. Speed. QPS showcases an animated logo to demonstrate how we embody the unique spirit of the hummingbird.
More than 25 years in the Business
QPS is celebrating 25 years in business in the year 2020! This year, we have expanded our capabilities to include RT-qPCR (COVID-19) and serological (novel coronavirus antibodies) testing.
Science Exchange Partnership
QPS partners with Science Exchange to make sure we are available in the most convenient places for you to plan your study.
QPS Assay Finder
The QPS Assay Finder contains details of over 800 assays that QPS has on-hand for your bioanalytical studies. Download the free App from the Apple Store, or from Google Play, or Click here to access the Assay Finder on this website.
Science Exhange Member
QPS is a member of Science Exchange. This versatile platform enables you to work with us with a minimum of preparation time.
QPS Holdings, LLC Sells QPS Neuropharmacology to Scantox
QPS announces an agreement to sell its Neuropharmacology business unit (QPS Neuropharmacology) to Scantox, a leading Nordic pre-clinical, GLP-accredited CRO.
French Research Tax Credit
QPS is delighted to announce that we have received accreditation for the French Research Tax Credit (CIR) for 2023, 2024, and 2025.